Key Sessions
Jennifer Joe
Drugs, Devices & Digital: Looking to the Future of Healthcare and Life Sciences
AstraZeneca
Herman Sanchez
Navigating the Pharma Deal Landscape: Achieving Successful Negotiations and Seamless Transactions
Trinity Life Sciences
Nabiha Saklayen
Startup Success: Securing an $80M Series A to Scale Regeneration Tech
Cellino Biotech
Helen Ho
Exploring Factors that Drive Biotech Deals: Areas of Focus and Future Strategies
Blueprint Medicines
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 2 – Thursday, 12 SEPTEMBER - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
Day 2 – Thursday, 12 SEPTEMBER - ET (Eastern Time, GMT-05:00)
search
Streams
Formats
8:00am - 9:00am
Registration & Breakfast
Showing 3 of 3 Streams
BIOTECH LEADERS MORNING KEYNOTE PLENARY
MEDTECH LEADERS
HEALTHTECH LEADERS
9:00am - 9:05am
LSX Welcome Address
- Adam Griffiths - Senior Director, Biotech Lead, Informa
9:05am - 10:00am
Navigating the Pharma Deal Landscape: Achieving Successful Negotiations and Seamless Transactions
- Herman Sanchez - Chief Business Officer, Trinity Life Sciences
- Michal Preminger - Head, Johnson & Johnson Innovation East North America, Johnson & Johnson
- Jon Kiburz - VP Transactions, R&D Business Development, GSK
- Ramlah Nehring - Global Head of Partnering, VP Strategy & Transactions, Roche
- Kendra Rose - Senior Vice President and Head of BD&L, Bayer
10:00am - 10:30am
Startup Success: Securing an $80M Series A to Scale Regeneration Tech
- Nabiha Saklayen - CEO & Founder, Cellino Biotech
- Anula Jayasuriya - Co-Founder, Kidron Capital
9:00am - 9:10am
LSX Welcome Address
9:10am - 9:50am
Bold Moves and Buyouts: The Medtech 2025 M&A Blueprint
- Wayne Jarvis - Senior Director BD & Portfolio Strategy, Coloplast
- Kevin Tahmoush - International Healthcare Executive, Former VP Business Development, BD
- Denise Clarke - Director, Strategy & Business Development, Philips Healthcare
- Natalya Shaykevich - Chief Business Development Officer, Halma
- Jim Parshall - Executive Director, Eli Lilly
9:50am - 10:30am
Medtech Payoff: The Foundations Of Successful Provider & Payer Relationships
- Christian Howell - Chief Commercial Officer, Cognito Therapeutics
- John Milad - CEO, ERS Genomics
9:00am - 9:10am
Welcome Address
9:10am - 9:50am
Leveraging Tech – How Can We Employ Data to Effectively Deliver on A Patient Centric Mission?
- Andrei Georgescu - CEO, Vivodyne
- Amit Garg - CEO, HiLabs
- Shruthi Bharadwaj - Global Lead, R&D Insights & Analytics, Sanofi
9:50am - 10:30am
Scaling RWE Generation & Integration
- Wendy Turenne - SVP, Real World Data & Operations, Aetion
- Joris Van Dam - VP Data Innovation, Exact Sciences
- Brian Clancy - RWD & RWE Partnerships Lead, Foundation Medicine
- Sherry Xiao - Senior Director, Integrated Evidence Generation, Pfizer
10:30am - 11:00am
MORNING BREAK
Showing 5 of 5 Streams
CAPITAL MARKETS & INVESTMENT
PARTNERSHIPS & DEAL MAKING
SCALING & COMMERCIALISATION
MEDTECH LEADERS
HEALTHTECH LEADERS
11:00am - 11:50am
Will IPOs Be Invite Only? Navigating the Journey to the Public Markets
- Leighanne Oh - VP, Ascenta Capital
- Adit Ghosh - Venture Capital Associate, NEA
- James Graham - CEO, Recce Pharmaceutical
11:50am - 12:40pm
Charting the Public Waters: The Biotech Public Market Outlook
- Mary Schaheen - President, Prevail Partners
- Lloyd Tran - Partner, TransPacific Venture Capital Partners
- Lee Cooper - Managing Director, Delos Capital
- Steve DiPalma - Managing Director, Danforth Advisors
- Troy Ignelzi - CFO, Rapport Therapeutics
12:40pm - 1:20pm
The Biotech Survival Guide: Advice for the Current Market and Forward Thinking
- Laura Berner - COO, TRexBio
- Bernard Cooney - Senior Partner, Flagship Pioneering
- Seth Lieblich - Principal, 8VC
- Nina Kjellson - General Partner, Canaan Partners
- Devin Rosenthal - VP & Head of Due Diligence, NovaQuest Capital Management
11:00am - 11:50am
Exploring Factors that Drive Biotech Deals: Areas of Focus and Future Strategies
- Helen Ho - CBO, Blueprint Medicines
- Ahmed Mousa - CEO, Vicore Pharma
- Faical Miyara - CBO, IO Biotech
- John Harlow - CCO, Melinta Therapeutics
11:50am - 12:40pm
Navigating Innovation: Strategic Insights into Licensing Approaches in Pharma and Biotech
- Armin Rump - Associate Director, Global Business Development, Otsuka
- Neel Desai - Executive Director, Business Development & Licensing, Biogen
- Christopher Tan - Executive Director, BD&L, Merck
- Andrew Whittle - Director, Strategic Partnering, Cardiometabolism & Retinal Health, Boehringer Ingelheim
12:40pm - 1:20pm
Partnering Early with Pharma to Achieve Transformative Innovation
- Alex Goddard - Director, Otsuka
- Lizabeth Leveille - VP BD&L, Head Boston & EU Innovation Hubs & Discovery Transactions, MSD
- Tom Hopkins - Global Head of Lilly ExploR&D, Eli Lilly
11:00am - 11:50am
What is Required to Scale? Fast-Tracking Biotech Growth
- Jake Becraft - CEO, Strand Therapeutics
- Wyatt McDonnell - CEO, Infinimmune, Inc.
- Ashley Zehnder, Ph.D. - CEO, Fauna Bio
- Minji Kim - CBO, Mineralys Therapeutics
11:50am - 12:40pm
Cultivating Success: Establishing an Outstanding Biotech Executive Team
- Leslie Loveless - CEO, Slone Partners
- Semi Trotto - Chief People Officer, Curie.Bio
- Elaine Cheung - CBO, Moonwalk Biosciences
- Lihua Zheng - Co-Founder & Chief Strategy Officer, AnHeart Therapeutics
- Bruce McCormick - CEO, Mercury Bio
12:40pm - 1:20pm
Considerations and Opportunities for Biotech & Pharma Within the APAC Region
- Jing Xu - Investment Principal, LYFE Capital
- Visali Ramanathan - Head of BD, Oncology, Genentech
- Donald Xu - Managing Partner, Lynx Capital
11:00am - 11:50am
MedTech's Sustainability Ultimatum: Innovate or Perish
- Rob Ellsworth - Global Director, Enterprise Sustainability, Medtronic
- Jamie Pero Parker - Sustainability Lead, RTI International
- Cal St. Denis - Global Director, Sustainability, Johnson and Johnson Medtech
11:50am - 12:40pm
Cash, Crew, and Commercialisation: A Startup's Journey to Success
- Ricardo dos Santos - Partner, Head of Venture Studio, Takeda Digital Ventures
- Carla Reimold - VP of Industry Strategy & Investments, Massachusetts Life Sciences Center
- Sergio Levi - Chief Strategy and Business Officer, Nitinotes Surgical
12:40pm - 1:20pm
The Rx for a Successful Exit
- Nate Harrington - Managing Partner, Philips
- Maria Shepherd - Executive Board Member, MedExec Women
- Giles Hamilton - Operating Partner, New Growth Advisors
- Kevin Reilly - Managing Director, Ally Bridge Group
11:00am - 11:50am
Healthtech is not Donkeys & Elephants – Making Healthcare Fairer & More Equitable Across the Nation
- Michael Pace - CEO & Co-Founder, PalmHealthCo
- Willie Reaves - Head of Public Engagement, Cellino
- Les Funtleyder - Portfolio Manager- Healthcare, E Squared Capital Management
- Ashok Chennuru - VP & Global Chief Data and Insights Officer, Carelon Digital Platforms
- Keely Benson - Director, Massachusetts eHealth Institute, MassTech
11:50am - 12:40pm
The Convergence of Biopharma, Medtech & Healthtech – What Does This Mean for The Future of Healthcare Delivery?
- Chris Leggett - Head of Global Commercial Innovation, Genmab
- Paul Geevarghese - Co-Founder & COO, 9amHealth
- Jim Parshall - Executive Director, Eli Lilly
- Jeff Chu - Managing Partner, Features Capital
12:40pm - 1:20pm
Unveiling CVC Investment Strategies in Digital Health & MedTech
- Alex de Winter - VP New Ventures, Danaher Ventures
- Suzie Yoon - Investment Principal, Takeda Digital Ventures
- Carrie Williams - VP & Partner, McKesson Ventures
- John Pavletic - Executive Director, Lilly Ventures
- Brenda Schmidt - Head of Strategic Growth and Innovation, Redesign Health
1:20pm - 2:20pm
LUNCH BREAK
Showing 1 of 1 Streams
LSX WORLD CONGRESS USA AFTERNOON KEYNOTE PLENARY
2:20pm - 3:10pm
What Does the 2024 Presidential Election Mean for Patients and Innovation?
- John Pracyk - SVP, Chief Medical Safety Officer - Global, Olympus Corporation
- Maria Shepherd - Executive Board Member, MedExec Women
- Haile Dagne - Director, Policy & Reimbursement, GSK
- Andy Molnar - CEO, Digital Therapeutics Alliance
- Rachel Hutman - CEO, Ford Hutman Media
3:10pm - 4:00pm
Drugs, Devices & Digital: Looking to the Future of Healthcare and Life Sciences
- Jennifer Joe - Global Medical Strategy & Population Health Director, AstraZeneca
- Steve Hahn - CEO-Partner, Flagship Pioneering
- Ravi Kaushik - VP, Global Head of Device & Digital Innovation & Prod Strategy, Plasma Derived Therapies, Takeda
- Emilia Javorksy - Director, Futures Program, Future of Life Institute
4:00pm - 4:05pm
CLOSE OF CONGRESS
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Formats